Suplatast-d5 (tosilate)

SL-9925

Suplatast-d₅ (tosilate), >98%

Related CAS No. : [94055-76-2] of the unlabelled compound

Synonyms : IPD 1151T-d₅

IUPAC Name : (3-((4-(3-(Ethoxy-d₅)-2-hydroxypropoxy)phenyl)amino)-3-oxopropyl)dimethylsulfonium 4-methylbenzenesulfonate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a deuterium labelled version of Suplatast tosilate, which is an orally administered inhibitor of Th2 cytokines, capable of suppressing both IL-4 and IL-5 production from Th2 cells as well as inhibiting IgE synthesis. Suplatast tosilate functions as an anti-allergic agent and exhibits antiasthmatic, anti-inflammatory, and antifibrotic properties.

References : Yanagihara Y. et al.: Jpn. J. Pharmacol., 61(1), 31-9, 1993; Zhao G. D. et al.: Int Arch Allergy Immunol., 121(2),116-22, 2000; Kurokawa M. et al.: Mediators Inflamm., 10(6), 333-337, 2001; Furonaka M. J. Pharmacol Exp Ther., 328(1), 55-61, 2009.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.